bpc-157 safety human adverse events and the Difference Between an Evidence Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded BPC 157 in Australia: Benefits,

Although its not fully understood, several factors appear to be at play: 1

All use of sermorelin should be under medical supervision with appropriate monitoring of efficacy and safety parameters

Always consult a licensed healthcare provider before using peptides or related supplements

Schedule: Daily subcutaneous injections for 4 weeks at a consistent dose, followed by a 24 week rest period to assess progress before considering another cycle

Unpublished data from the 2015, 2016 and 2017 Behavioral Risk Factor Surveillance System survey, analyzed by and provided to the Alzheimer's Association by the Alzheimer's Disease and Healthy Aging Program (AD+HP), Centers for Disease Control and Prevention (CDC)